Douglas I Laird, PA-C | |
700 Scott And White Dr, College Station, TX 77845-6441 | |
(979) 207-0100 | |
(979) 207-2161 |
Full Name | Douglas I Laird |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Location | 700 Scott And White Dr, College Station, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144264193 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | PA02267 (Texas) | Secondary |
363A00000X | Physician Assistant | 02267 (Texas) | Secondary |
363A00000X | Physician Assistant | PA02267 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Douglas I Laird, PA-C Po Box 844658, Dallas, TX 75284-4658 Ph: (254) 724-2111 | Douglas I Laird, PA-C 700 Scott And White Dr, College Station, TX 77845-6441 Ph: (979) 207-0100 |
News Archive
Body dysmorphic disorder is a disabling but often misunderstood psychiatric condition in which people perceive themselves to be disfigured and ugly, even though they look normal to others. New research at UCLA shows that these individuals have abnormalities in the underlying connections in their brains.
Kidney failure is a significant risk for patients undergoing cardiopulmonary bypass surgery, radiologic testing, antibiotic therapy or in patients suffering from severe infections. More than 80 percent of patients with postoperative acute renal failure die.
Current use of prenatal ultrasounds in women with singleton pregnancies is 55% greater than in 1996, even in low-risk pregnancies. More than one-third (37%) of pregnant women now receive 3 or more ultrasound tests in the second and third trimesters of a given pregnancy, found an article http://www.cmaj.ca/embargo/cmaj090979.pdf in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.
Teva Pharmaceutical Industries Ltd. announced today that a jury returned a verdict in the U.S. District Court for the District of New Jersey finding that Nycomed's U.S. Patent No. 4,758,579 is not invalid. The Court has reserved decision on the issue of what, if any, effect to give to the jury's determinations in connection with the obviousness-type double patenting defenses, which Teva has argued is to be decided by the Court.
The first members of WHO's international team arrived in Abidjan this week to support the Ministry of Health in dealing with an environmental health emergency caused by toxic waste.
› Verified 7 days ago